First Citizens Bank & Trust Co. acquired a new stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) in the first quarter, HoldingsChannel.com reports. The fund acquired 6,689 shares of the medical instruments supplier’s stock, valued at approximately $332,000.
Several other institutional investors and hedge funds have also recently made changes to their positions in XRAY. Morgan Stanley grew its position in shares of DENTSPLY SIRONA by 1,233.9% in the 3rd quarter. Morgan Stanley now owns 5,242,702 shares of the medical instruments supplier’s stock valued at $197,860,000 after acquiring an additional 4,849,652 shares during the period. Norges Bank bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $73,734,000. DNB Asset Management AS grew its position in shares of DENTSPLY SIRONA by 1,649.5% in the 4th quarter. DNB Asset Management AS now owns 1,924,560 shares of the medical instruments supplier’s stock valued at $71,613,000 after acquiring an additional 1,814,556 shares during the period. Mackenzie Financial Corp grew its position in shares of DENTSPLY SIRONA by 17.3% in the 4th quarter. Mackenzie Financial Corp now owns 10,090,056 shares of the medical instruments supplier’s stock valued at $375,451,000 after acquiring an additional 1,490,134 shares during the period. Finally, Consulta Ltd bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $29,768,000. 96.30% of the stock is owned by institutional investors.
Shares of DENTSPLY SIRONA stock opened at $50.38 on Wednesday. DENTSPLY SIRONA Inc has a twelve month low of $33.93 and a twelve month high of $51.50. The company has a quick ratio of 1.27, a current ratio of 1.86 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $11.40 billion, a price-to-earnings ratio of 25.06, a price-to-earnings-growth ratio of 2.30 and a beta of 1.11.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, March 1st. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.04. DENTSPLY SIRONA had a negative net margin of 25.36% and a positive return on equity of 8.21%. The business had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the previous year, the company earned $0.82 EPS. The business’s revenue was down 2.9% on a year-over-year basis. As a group, equities research analysts expect that DENTSPLY SIRONA Inc will post 2.31 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a $0.087 dividend. This represents a $0.35 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend was Thursday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is currently 17.41%.
A number of brokerages have recently commented on XRAY. BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, March 22nd. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Sunday, January 6th. UBS Group began coverage on shares of DENTSPLY SIRONA in a research report on Thursday, January 17th. They issued a “neutral” rating and a $42.00 price objective for the company. William Blair raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $56.71 price objective for the company in a research report on Monday, March 18th. Finally, HC Wainwright set a $49.00 price objective on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a research report on Friday, April 5th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $52.12.
ILLEGAL ACTIVITY NOTICE: This report was posted by Stock Observer and is the property of of Stock Observer. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.thestockobserver.com/2019/04/17/first-citizens-bank-trust-co-invests-332000-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.